Trials / Sponsors / Legend Biotech USA Inc
Legend Biotech USA Inc
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung | Phase 1 | 2023-07-26 |
| Active Not Recruiting | Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Me Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer | Phase 1 | 2023-04-18 |
| Unknown | Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma Refractory | Phase 1 | 2021-09-13 |